Medtronic Korea designated Seoul National University Hospital Neurosurgery Department (E Seoul National University Hospital Neurosurgery Clinic) as the’Center of Excellence (Medtronic APAC NS Training Center)’ and monitored neurosurgery during surgery by domestic and foreign neurosurgeons It was announced on the 3rd that it had signed a mutual business agreement (MOU) for skills training.
Seoul National University Hospital Director Kim Yeon-soo and Neurosurgery Professor Kim Seung-gi, neurosurgery professor Kim Yong-hui, medical school vice president Kim Jeong-un, Medtronic Korea vice president Seung-rok Yoo, and vice president Park Tae-hee attended the business agreement signing ceremony.
Through this business agreement, the two organizations operate an educational program using NIM Eclipse E4, Medtronic’s latest intraoperative neurosurveillance monitoring device, for domestic and foreign neurosurgeons, and provide an academic exchange environment based on close cooperation.
Until January of next year, Seoul National University Hospital Neurosurgery Clinic is the first NIM Eclipse educational institution in Asia-Pacific to provide overall understanding of neurosurveillance monitoring during surgery and strengthen skills of medical staff participating in the program ▲ surgical skills practice ▲ lectures ▲ medical device practice, etc. Plan.
Seoul National University Hospital Hospital Director Kim Yeon-soo said, “We hope that this business agreement will serve as another opportunity to expand the role of Seoul National University Hospital as the backbone of medical education.”
Neurosurgery Chief Kim Seung-gi said, “‘Nerve monitoring during surgery’ is an essential system that minimizes the risk of nerve damage that may occur during neurological surgery such as the brain and spinal cord, and helps the patient’s safety through careful tracking.” “I am very pleased to be able to pass on the experience and knowledge of neurosurveillance monitoring accumulated by neurosurgery to domestic and foreign medical staff and make progress together.”
Seungrok Yoo, Managing Director of Medtronic Korea said, “This meaningful MOU will not only inform the necessity of neurosurveillance monitoring during surgery, but also play a major role in the development of medical technology.” “Medtronic will continue to be an innovative medical device for the healthy life of patients. We will continue to support development, research and education.”